Authors: Khayati, F. / Fernández-Recio, Juan / Pérez, L. / Villoutreix, B. / Calvo, F. / Lebbe, C. / Menashi, S. / Mourah, S.
Publication: Fund. Clin. Pharm.
Volume / Pagination: 28 / 4-4
Keywords: EMMPRIN/CD147, targeted therapy, tumor angiogenesis, VEGFR-2